Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 1, Number 11, November 2003

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Free Content The factor VIII assay problem: neither rhyme nor reason
pp. 2275-2279(5)
Author: Lollar, P.

Favourites:
ADD
Favourites:
ADD

Free Content A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standards
pp. 2283-2289(7)
Authors: Morfini, M.; Cinotti, S.; Bellatreccia, A.; Paladino, E.; Gringeri, A.; Mannucci, P. M.

Favourites:
ADD

Free Content Effects of statins on adhesion molecule expression in endothelial cells
pp. 2290-2299(10)
Authors: Dimitrova, Y.; Dunoyer-Geindre, S.; Reber, G.; Mach, F.; Kruithof, E. K. O.; De Moerloose, P.

Favourites:
ADD

Free Content Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia
pp. 2300-2311(12)
Authors: Wilcox, D. A.; White II, G. C.

Favourites:
ADD

Free Content Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction
pp. 2312-2316(5)
Authors: Lowe, G. D. O.; Woodward, M.; Rumley, A.; Morrison, C. E.; Nieuwenhuizen, W.

Favourites:
ADD

Free Content The β fibrinogen gene G-455-A polymorphism is a risk factor for Legg–Perthes disease
pp. 2317-2321(5)
Authors: Dilley, A.; Hooper, W. C.; Austin, H.; Jamil, M.; Miller, C.; Stokes, M.; Evatt, B.; Eldridge, J.

Favourites:
ADD

Free Content The plasminogen activator inhibitor-1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study
pp. 2322-2329(8)
Authors: Juhan-Vague, I.; Morange, P. E.; Frere, C.; Aillaud, M. F.; Alessi, M. C.; Hawe, E.; Boquist, S.; Tornvall, P.; Yudkin, J. S.; Tremoli, E.; Margaglione, M.; Di Minno, G.; Hamsten, A.; Humphries, S. E.

Favourites:
ADD

Free Content Leptin increase is associated with markers of the hemostatic system in obese healthy women
pp. 2330-2334(5)
Authors: Guagnano, M. T.; Romano, M.; Falco, A.; Nutini, M.; Marinopiccoli, M.; Manigrasso, M. R.; Basili, S.; Davì, G.

Favourites:
ADD

Free Content Knowledge and educational needs of individuals with the factor V Leiden mutation
pp. 2335-2339(5)
Authors: Hellmann, E. A.; Leslie, N. D.; Moll, S.

Favourites:
ADD

Free Content Factor XI apple domains and protein dimerization
pp. 2340-2347(8)
Authors: Cheng, Q.; Sun, M.-F.; Kravtsov, D. V.; Aktimur, L, A.; Gailani, D.

Favourites:
ADD

Free Content Hypofibrinogenemia caused by a nonsense mutation in the fibrinogen Bβ chain gene
pp. 2356-2359(4)
Authors: Mimuro, J.; Hamano, A.; Tanaka, T.; Madoiwa, K. S.; Sugo, T.; Matsuda, M.; Sakata, Y.

Favourites:
ADD

Free Content LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII
pp. 2360-2367(8)
Authors: Cunningham, M. A.; Pipe, S. W.; Zhang, B.; Hauri, H.-P.; Ginsburg, D.; Kaufman, R. J.

Favourites:
ADD

Free Content Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux
pp. 2368-2373(6)
Authors: Lisman, T.; Bijsterveld, N. R.; Adelmeijer, J.; Meijers, J. C. M.; Levi, M.; Nieuwenhuis, H. K.; De Groot, P. G.

Favourites:
ADD

Free Content Monitoring the bioavailability of FEIBA with a thrombin generation assay
pp. 2374-2380(7)
Authors: Váradi, K.; Negrier, C.; Berntorp, E.; Astermark, J.; Bordet, J.-C.; Morfini, M.; Linari, S.; Schwarz, H. P.; Turecek, P. L.

Favourites:
ADD

Free Content A common mutation, Arg457→Gln, links prothrombin deficiencies in the Puerto Rican population
pp. 2381-2388(8)
Authors: Lefkowitz, J. B.; Weller, A.; Nuss, R.; Santiago-Borrero, P. J.; Brown, D. L.; Ortiz, I. R.

Favourites:
ADD

Free Content Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice
pp. 2389-2396(8)
Authors: Eren, M.; Painter, C. A.; Gleaves, L. A.; Schoenhard, J. A.; Atkinson, J. B.; Brown, N. J.; Vaughan, D. E.

Favourites:
ADD

Free Content Population-based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in Japanese: the Suita Study
pp. 2397-2403(7)
Authors: Okamoto, A.; Sakata, T.; Mannami, T.; Baba, S.; Katayama, Y.; Matsuo, H.; Yasaka, M.; Minematsu, K.; Tomoike, H.; Miyata, T.

Favourites:
ADD

Free Content Effect of cellular and receptor activation on the extent of integrin αIIbβ3 internalization
pp. 2404-2410(7)
Authors: Schober, J. M.; Lam, S. C. -T.; Wencel-Drake, J. D.

Favourites:
ADD

Free Content Differences and similarities in tyrosine phosphorylation of proteins in platelets from human and pig species
pp. 2411-2418(8)
Authors: Zurbano, M. J.; Fusté, B.; Arderiu, G.; Escolar, G.; Ordinas, A.; Díaz-Ricart, M.

Favourites:
ADD

Free Content c-Cbl negatively regulates platelet activation by glycoprotein VI
pp. 2419-2426(8)
Authors: Auger, J. M.; Best, D.; Snell, D. C.; Wilde, J. I.; Watson, S. P.

Favourites:
ADD

Free Content Glanzmann's thrombasthenia due to a point mutation within intron 10 results in aberrant splicing of the β3 gene
pp. 2427-2433(7)
Authors: Tanaka, S.; Hayashi, T.; Terada, C.; Hori, Y.; Han, K. S.; Ahn, H. S.; Bourre, F.; Tani, Y.

Favourites:
ADD

Free Content Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo
pp. 2434-2443(10)
Authors: Abid Hussein, M. N.; Meesters, E. W.; Osmanovic, N.; Romijn, F. P. H. TH. M.; Nieuwland, R.; Sturk, A.

Favourites:
ADD

Free Content Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells
pp. 2444-2449(6)
Authors: Fernando, L.P.; Fernando, A.N.; Joseph, K.; Kaplan, A.P.

Favourites:
ADD

Free Content Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients
pp. 2445-2446(2)
Authors: Roussel-Robert, V.; Torchet, M. F.; Legrand, F.; Rothschild, C.; Stieltjes, N.

Favourites:
ADD

Free Content Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients
pp. 2450-2451(2)
Authors: Roussel-Robert, V.; Torchet, M. F.; Legrand, F.; Rothschild, C.; Stieltjes, N.

Favourites:
ADD

Free Content Factor V Leiden G1691A and prothrombin G20210A mutations are common in Tunisia
pp. 2451-2452(2)
Authors: Frere, C.; Saut, N.; Boukef, M. K.; Zili, M.; Toumi, N. E. H.

Favourites:
ADD

Free Content Successful use of Arixtra® in a patient with paroxysmal nocturnal hemoglobinuria, Budd–Chiari syndrome and heparin-induced thrombocytopenia
pp. 2452-2453(2)
Authors: D'Amico, E. A.; Villaça, P. R.; Gualandro, S. F. M.; Bassitt, R. P.; Chamone, D. A. F.

Favourites:
ADD

Free Content Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation
pp. 2453-2455(3)
Authors: Di Lecce, V. N.; Loffredo, L.; Fimognari, F. L.; Cangemi, R.; Violi, F.

Favourites:
ADD
Favourites:
ADD

Free Content Talking about ...
pp. 2460-2461(2)
Authors: Bruttomesso, G.; Miglino, N.

Favourites:
ADD

Free Content Announcements
pp. 2462-2462(1)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more